000			04022nam a22004335i 4500
999			_c6533 _d6533
001			6533
003			ES-MaUEC
005			20201203160817.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			200125s2020 gw | s |||| 0|eng d
020			_a9783030333041
024	7		_a10.1007/978-3-030-33304-1 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRM666 _b.S73 2020 EB
245	0	0	_aStatin-Associated Muscle Symptoms _cedited by Paul D. Thompson, Beth A. Taylor.
250			_a1st ed. 2020.
264		1	_aCham _bSpringer International Publishing : _bImprint: Springer _c2020.
300			_a1 recurso en línea (XI, 188 páginas) _b22 ilustraciones, 16 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aContemporary Cardiology _x2196-8969
490	0		_aMedicine (Springer-11650)
505	0		_aChapter 1. Introduction -- Chapter 2. Do Statin-Associated Muscle Symptoms (SAMS) Exist? -- Chapter 3. The Clinical Presentation of SAMS -- Chapter 4. Definitions of SAMS -- Chapter 5. The Patient's Perspective of SAMS -- Chapter 6. Psychosocial, Emotional, and Societal Factors Influencing Perceptions and Experiences of SAMS -- Chapter 7. Prevalence of SAMS in Observational and Clinical Trials -- Chapter 8. Risk factors for SAMS -- Chapter 9. Clinical Trials of Treatments for SAMS -- Chapter 10. Clinical Management of SAMS -- Chapter 11. Effects of Statins on Exercise Performance and Exercise Training -- Chapter 12. Genetic Risk Factors for SAMS -- Chapter 13. The Role of the Mitochondria in SAMS -- Chapter 14. The Role of Energy Metabolism in SAMS -- Chapter 15. Vitamin D and SAMS -- Chapter 16. Coenzyme Q 10 and SAMS -- Chapter 17. Diagnosing SAMS -- Chapter 18. The Clinical and Financial Cost of SAMS -- Chapter 19. The Interaction of Statins and Inherited Muscle Disease -- Chapter 20. The Differential Diagnosis of SAMS -- Chapter 21. Statin-Associated Inflammatory Myositis and Other Inflammatory Conditions -- Chapter 22. Managing Statin Rhabdomyolysis -- Chapter 23. Future Directions: Critical Questions and Research Approaches to Improving Understanding and Treatment of SAMS.
520	3		_aThis book provides an overview of statin-associated muscle symptoms (SAMS) from clinical presentation to treatment and possible metabolic causes. It examines the risk factors, presentations, diagnosis and differential diagnosis, clinical management, and financial costs of SAMS. The book also highlights patients' perspectives on SAMS such as the psychosocial, emotional, and societal factors influencing their perceptions and experiences. Finally, the book presents the results of observational and clinical trials on the prevalence of SAMS, clinical trials for treatments, and potential future research approaches for improving the understanding and treatment of SAMS. A key addition to the Contemporary Cardiology series, Statin-Associated Muscle Symptoms is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in cardiology, endocrinology, pharmacotherapy, primary care, and health promotion and disease prevention.
988			_aPrimersemestre_2020_Medicine
650		7	_2embne _9672615 _aInhibidores de HMG-CoA reductasas
700	1		_aThompson, Paul D. _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt _930396
700	1		_aTaylor, Beth A. _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service) _9106937
776	0	8	_iPrinted edition: _z9783030333034
776	0	8	_iPrinted edition: _z9783030333058
776	0	8	_iPrinted edition: _z9783030333065
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-33304-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE _n0
998			_db _zSI